Shane Olwill Pieris Pharmaceuticals, Inc. (PIRS) insider trading activity

PIRS Quotes by TradingView

Shane Olwill is Chief Development Officer of PIERIS PHARMACEUTICALS, INC.. Currently has a direct ownership of 4,638 shares of PIRS, which is worth approximately $34,645. The most recent transaction as insider was on Aug 30, 2021, when has been sold 38,400 shares (Common Stock) at a price of $5.08 per share, resulting in proceeds of $195,072. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.64K
0% 3M change
0% 12M change
Total Value Held $34,645

Shane Olwill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2021
SELL
Open market or private sale
$195,072 $5.08 p/Share
38,400 Reduced 89.22%
4,638 Common Stock
Aug 30 2021
BUY
Exercise of conversion of derivative security
$58,368 $1.52 p/Share
38,400 Added 47.15%
43,038 Common Stock
SO

Shane Olwill

Chief Development Officer
Boston, MA

Track Institutional and Insider Activities on PIRS

Follow PIERIS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PIRS shares.

Notify only if

Insider Trading

Get notified when an Pieris Pharmaceuticals, Inc. insider buys or sells PIRS shares.

Notify only if

News

Receive news related to PIERIS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PIRS